Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane for subjective tinnitus
2009-011246-25Phase 3Completed
- Sponsor
- Merz
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of neramexane in tinnitus (4 arms), sponsored by Merz. Primary endpoint: Primary efficacy endpoint. Started Sep 2009; status: completed.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2009-011246-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011246-25.